A new transformative approach to defining, studying and treating Parkinson’s disease has been revealed by investigators. Rather than approaching Parkinson’s disease as a single entity, the international cadre of researchers advocates targeting therapies to distinct ‘nodes or clusters’ of patients based on specific symptoms or molecular features of their disease.